Medical Product Earnings On Jul 21: ABAX, ATHN, NURO, SYK

Medical is one of the seven sectors in the S&P 500 that is expected to report earnings growth in the second quarter.

As per the latest Zacks Earnings Trend report, overall second-quarter earnings for S&P 500 companies are expected to be down 5.4% from the year-ago quarter on revenues that are estimated to decline 0.5%.

On the other hand, Medical is estimated to report earnings growth of 0.5% on revenue growth of 7.7%. Medical product is an important component of the medical sector and is expected to follow the same earnings growth trajectory in the quarter.

Here we take a sneak peek into four major medical product companies lined up to report earnings on Jul 21.

Stryker Corporation SYK is set to report its quarterly figures, after market close. The company’s expanding product portfolio is a key catalyst in our view. Moreover, back-to-back acquisitions of the likes of Physio-Control International, Synergetics USA and Sage Products LLC are expected to drive overall growth.

STRYKER CORP Price and EPS Surprise

STRYKER CORP Price and EPS Surprise | STRYKER CORP Quote

However, our proven model does not conclusively show that the company is likely to beat earnings, given the combination of a Zacks Rank #3 (Hold) and Earnings ESP of 0.00%.

That is because, as per our model, a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 or 3 to beat earnings. Simultaneously, we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
 
athenahealth ATHN is scheduled to report second-quarter earnings, after the closing bell. We believe that the company’s strong product portfolio, expanding physician base and unique business model will enhance the growth prospects of the company.

ATHENAHEALTH IN Price and EPS Surprise

ATHENAHEALTH IN Price and EPS Surprise | ATHENAHEALTH IN Quote

However, our proven model does not conclusively show that the company is likely to beat earnings, given the combination of a Zacks Rank #3 and Earnings ESP of 0.00%.

Manufacturer of portable Medical (human) and Veterinary (animal) blood analysis systems, Abaxis Inc ABAX is expected to report results after market close.  The company is a leading name in the veterinary market, thanks to its consistent strong sales from veterinary consumables business franchises. Moreover, the strong portfolio of consumable products looks promising.

ABAXIS INC Price and EPS Surprise

ABAXIS INC Price and EPS Surprise | ABAXIS INC Quote

However, our proven model does not conclusively show that the company is likely to beat earnings, given the combination of a Zacks Rank #3 and Earnings ESP of 0.00%.

We also note that Abaxis’ results compared favorably with the Zacks Consensus Estimate in the last four quarters, with an average beat of 8.1%.

NeuroMetrix Inc. NURO develops wearable medical technology and point-of-care tests. We believe the company has got significant growth opportunities, primarily driven by the business units of Advance NCS system, SENSUS pain management system, DPNCheck and Quell.

NEUROMETRIX INC Price and EPS Surprise

NEUROMETRIX INC Price and EPS Surprise | NEUROMETRIX INC Quote

Nevertheless, our proven model does not conclusively show that the company is likely to beat earnings, given the combination of a Zacks Rank #3 and Earnings ESP of 0.00%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ATHENAHEALTH IN (ATHN): Free Stock Analysis Report
 
STRYKER CORP (SYK): Free Stock Analysis Report
 
ABAXIS INC (ABAX): Free Stock Analysis Report
 
NEUROMETRIX INC (NURO): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Comments on ATHN stock

Do share this awesome post